Bandingkan Harga & Kinerja Sumber Sinergi Makmur Tbk. (IOTF) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sumber Sinergi Makmur Tbk. dan Organon Pharma Indonesia Tbk.: Sumber Sinergi Makmur Tbk. diperdagangkan di Rp62 (kapitalisasi pasar 338,58 M, volume 24 jam 17,89 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Sumber Sinergi Makmur Tbk. jauh lebih besar — sekitar 3,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IOTF | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 338,58 M | 104,4 M |
Volume | 17,89 jt | — |
Lot | 178,94 rb | — |
Perputaran | 1,13 M | — |
Harga Rata-rata | 62,89 | — |
Nilai Transaksi | 1,13 M | — |
Harga Ekuilibrium Indikatif | 62 | — |
Volume Ekuilibrium Indikatif | 15,21 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sumber Sinergi Makmur Tbk.
PT Sumber Sinergi Makmur Tbk (the Company) was established based on Deed Number 88 dated May 19, 2015 of H. Zainuddin, S.H., a notary domiciled in Jakarta. The company started its commercial activities in 2015. The controlling party of the Company and the party who is the ultimate beneficial owner of the Company is Alamsyah.
Selengkapnya di halaman IOTF →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
